多重用药及高风险药物类别与苏格兰1型糖尿病人群不良健康结局的关联
基于苏格兰全国糖尿病登记库28,245例1型糖尿病患者,分析基线处方药数量及高风险药物类别与随后一年跌倒住院、糖尿病酮症酸中毒(DKA)、低血糖住院或死亡的关联。校正年龄、性别、地区社会经济剥夺和健康状况后,每增加一种药物与跌倒、低血糖住院及死亡风险升高相关,DKA住院关联不显著。多重用药常见且随年龄增长,抗血栓/抗凝药、糖皮质激素、阿片类等药物类别与不良结局风险升高相关。
要点
- 每增加一种处方药,跌倒住院风险HR 1.03(95%CI 1.01–1.06),低血糖住院HR 1.05(1.02–1.07),死亡HR 1.04(1.02–1.06)。
- DKA住院与每增加一种药物的关联无统计学意义(HR 1.01,95%CI 1.00–1.03)。
- 抗血栓/抗凝药、糖皮质激素、阿片类、抗癫痫药、抗精神病药、催眠镇静药和抗抑郁药与至少一种不良结局风险升高相关。
核心结论
- 在苏格兰1型糖尿病人群中,多重用药常见且随年龄增长,处方药数量及特定高风险药物类别是跌倒、低血糖住院和死亡风险升高的强标志。
研究设计与样本
- 基于苏格兰人群糖尿病登记库的全国队列研究,纳入2017年1月1日诊断为1型糖尿病的28,245例个体,采用多变量Cox比例风险模型分析基线用药与随后一年不良结局的关联。
主要发现
- 不计算胰岛素和低血糖治疗药物,平均处方药数量为4.00(SD 4.35)。
- 处方5种及以上药物的比例随年龄增长:0–19岁2.04%(95%CI 1.60–2.49),40–49岁28.50%(27.08–29.93),80岁及以上76.04%(67.73–84.84)。
- 校正年龄、性别、地区社会经济剥夺和健康状况后,每增加一种基线药物与跌倒住院(HR 1.03,95%CI 1.01–1.06)、低血糖住院(HR 1.05,1.02–1.07)和死亡(HR 1.04,1.02–1.06)风险升高相关,DKA住院关联无统计学意义(HR 1.01,1.00–1.03)。
- 抗血栓/抗凝药、糖皮质激素、阿片类、抗癫痫药、抗精神病药、催眠镇静药和抗抑郁药与至少一种不良健康结局风险升高相关。
临床怎么用
- 对1型糖尿病合并多重用药者,应评估跌倒、低血糖和死亡风险,尤其关注高龄及使用抗血栓/抗凝药、糖皮质激素、阿片类、抗癫痫药、抗精神病药、催眠镇静药和抗抑郁药的患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: The aim of this work was to map the number of prescribed drugs over age, sex and area-based socioeconomic deprivation, and to examine the association between the number of drugs and particular high-risk drug classes with adverse health outcomes among a national cohort of individuals with type 1 diabetes. METHODS: Utilising linked healthcare records from the population-based diabetes register of Scotland, we identified 28,245 individuals with a diagnosis of type 1 diabetes on 1 January 2017. For this population, we obtained information on health status, predominantly reflecting diabetes-related complications, and information on the total number of drugs and particular high-risk drug classes prescribed. We then studied the association of these baseline-level features with hospital admissions for falls, diabetic ketoacidosis (DKA), and hypoglycaemia or death within the subsequent year using multivariate Cox proportional hazards models. RESULTS: Not considering insulin and treatment for hypoglycaemia, the mean number of prescribed drugs was 4.00 (SD 4.35). The proportion of individuals being prescribed five or more drugs at baseline consistently increased with age (proportion [95% CI]: 0-19 years 2.04% [1.60, 2.49]; 40-49 years 28.50% [27.08, 29.93]; 80+ years 76.04% [67.73, 84.84]). Controlling for age, sex, area-based socioeconomic deprivation and health status, each additional drug at baseline was associated with an increase in the hazard for hospitalisation for falls, hypoglycaemia and death but not for DKA admissions (HR [95% CI]: falls 1.03 [1.01, 1.06]; DKA 1.01 [1.00, 1.03]; hypoglycaemia 1.05 [1.02, 1.07]; death 1.04 [1.02, 1.06]). We found a number of drug classes to be associated with an increased hazard of one or more of these adverse health outcomes, including antithrombotic/anticoagulant agents, corticosteroids, opioids, antiepileptics, antipsychotics, hypnotics and sedatives, and antidepressants. CONCLUSIONS: Polypharmacy is common among the Scottish population with type 1 diabetes and is strongly patterned by sociodemographic factors. The number of prescribed drugs and the prescription of particular high-risk drug classes are strong markers of an increased risk of adverse health outcomes, including acute complications of diabetes.
引用
- Höhn A, Jeyam A, Caparrotta TM, et al. The association of polypharmacy and high-risk drug classes with adverse health outcomes in the Scottish population with type 1 diabetes. Diabetologia. 2021. PMID: 33608768. doi:10.1007/s00125-021-05394-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。